Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Akebia Therapeutics Inc
SWB:AX9
Akebia Therapeutics Inc
SWB:AX9
Price:
1.124
EUR
-1.45%
Market Closed
Market Cap:
€374.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Akebia Therapeutics Inc
SWB:AX9
|
US |
|
Marisa Lojas SA
BOVESPA:AMAR3
|
BR |
|
Giant Motorsports Inc
OTC:BZRD
|
US |
|
D
|
Dohome PCL
SET:DOHOME
|
TH |
|
S
|
Sun Life Financial Inc
LSE:0VJA
|
CA |
|
CAE Inc
NASDAQ:CAE
|
CA |
|
G
|
Green Plains Inc
F:G3V
|
US |
|
M
|
MetaLabs Co Ltd
KRX:090370
|
KR |
|
S
|
Sasol Ltd
XMUN:SAOA
|
ZA |
|
G
|
Graphisoft Park SE Ingatlanfejleszto Europai Rt
F:GUV
|
HU |
|
China United Insurance Service Inc
OTC:CUII
|
TW |
|
Agios Pharmaceuticals Inc
NASDAQ:AGIO
|
US |
|
Promotora y Operadora de Infraestructura SAB de CV
OTC:PUODY
|
MX |
|
Celanese Corp
NYSE:CE
|
US |
|
All American Gold Corp
OTC:AAGC
|
US |
|
N
|
ND Rubber PCL
SET:NDR
|
TH |
|
Erste Group Bank AG
VSE:EBS
|
AT |
|
A
|
ALD SA
PAR:AYV
|
FR |
|
A
|
Anika Therapeutics Inc
F:AKP
|
US |
|
A
|
Avila Energy Corp
CNSX:VIK
|
CA |
|
C
|
Coocon Corp
KOSDAQ:294570
|
KR |
|
G
|
Grindr Inc
NYSE:GRND
|
US |
Wall St Price Targets
AX9 Price Forecast
Based on 7 analysts
Based on 7 analysts
+217% Upside
from
€1.124
today
Akebia Therapeutics Inc (AX9)’s 12-month stock price forecast through August 2027 has a consensus target of €3.559, implying 217% upside. The forecast is based on price targets from 7 Wall Street analysts.
AX9 Analyst Rating
No ratings yet
No ratings yet
Akebia Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is AX9's stock price target?
Price Target
3.559
EUR
3.559
EUR
According to Wall Street analysts, the average 1-year price target for AX9 is 3.559 EUR with a low forecast of 0.881 EUR and a high forecast of 5.496 EUR.
What is the Revenue forecast for Akebia Therapeutics Inc?
Projected CAGR
9%
9%
The compound annual growth rate for Revenue over the next 8 years is 9%.
What is the Gross Profit forecast for Akebia Therapeutics Inc?
Projected CAGR
-9%
-9%
The compound annual growth rate for Gross Profit over the next 3 years is -9%.
What is the Operating Income forecast for Akebia Therapeutics Inc?
Projected CAGR
34%
34%
The compound annual growth rate for Operating Income over the next 8 years is 34%.